scholarly journals Surfactants, Aromatic and Isoprenoid Compounds, and Fatty Acid Biosynthesis Inhibitors Suppress Staphylococcus aureus Production of Toxic Shock Syndrome Toxin 1

2009 ◽  
Vol 53 (5) ◽  
pp. 1898-1906 ◽  
Author(s):  
Peter J. McNamara ◽  
Rae Ellen Syverson ◽  
Kathy Milligan-Myhre ◽  
Olga Frolova ◽  
Sarah Schroeder ◽  
...  

ABSTRACT Menstrual toxic shock syndrome is a rare but potentially life-threatening illness manifest through the actions of Staphylococcus aureus toxic shock syndrome toxin 1 (TSST-1). Previous studies have shown that tampon additives can influence staphylococcal TSST-1 production. We report here on the TSST-1-suppressing activity of 34 compounds that are commonly used additives in the pharmaceutical, food, and perfume industries. Many of the tested chemicals had a minimal impact on the growth of S. aureus and yet were potent inhibitors of TSST-1 production. The TSST-1-reducing compounds included surfactants with an ether, amide, or amine linkage to their fatty acid moiety (e.g., myreth-3-myristate, Laureth-3, disodium lauroamphodiacetate, disodium lauramido monoethanolamido, sodium lauriminodipropionic acid, and triethanolamine laureth sulfate); aromatic compounds (e.g. phenylethyl and benzyl alcohols); and several isoprenoids and related compounds (e.g., terpineol and menthol). The membrane-targeting and -altering effects of the TSST-1-suppressing compounds led us to assess the activity of molecules that are known to inhibit fatty acid biosynthesis (e.g., cerulenin, triclosan, and hexachlorophene). These compounds also reduced S. aureus TSST-1 production. This study suggests that more additives than previously recognized inhibit the production of TSST-1.

Author(s):  
NANCY E. THOMPSON ◽  
MERLIN S. BERGDOLL ◽  
RICHARD F. MEYER ◽  
REGINALD W. BENNETT ◽  
LLONAS MILLER ◽  
...  

2019 ◽  
Vol 112 (4) ◽  
pp. 1163-1177 ◽  
Author(s):  
Stephen W. Tuffs ◽  
Christine A. Herfst ◽  
Miren L. Baroja ◽  
Vladyslav A. Podskalniy ◽  
Erica N. DeJong ◽  
...  

2019 ◽  
Vol 160 (48) ◽  
pp. 1887-1893
Author(s):  
Bálint Gergely Szabó ◽  
Rebeka Kiss ◽  
Katalin Szidónia Lénárt ◽  
Nikolova Radka ◽  
Béla Kádár

Abstract: Streptococcal toxic shock syndrome (STSS) is a hyperacute, life-threatening illness, a complication of invasive streptococcal (mostly group A, rarely groups B, G or C) infection. There is no portal of entry (skin, vagina, pharynx) in nearly half of the STSS cases. The initial signs and symptoms (fever, flu-like complaints, hypotension) are scarce and aspecific, but because of its rapid progression and poor prognosis, early high level of suspicion is necessary. Management has 3 crucial points: initiation of anti-streptococcal regimen (and intravenous immunoglobulin in some cases), aggressive intensive care support of multi-organ failure, and surgical control of the infective source. In this article, we present a case of a patient succumbing to streptococcal toxic shock syndrome which was preceded by primary S. pyogenes bacteremia, and review the key points of this potentially fatal disease for practising clinicians. Orv Hetil. 2019; 160(48): 1887–1893.


Sign in / Sign up

Export Citation Format

Share Document